Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference

Affiliations

• ¹ Mount Sinai Liver Cancer Program, Division of Liver Diseases, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY.
• ² Translational Research in Hepatic Oncology, Liver Unit, IDIBAPS, Hospital Clinic, University of Barcelona, Barcelona, Spain.
• ³ Institució Catalana d'Estudis Avançats (ICREA), Barcelona, Spain.
• ⁴ UT Southwestern Medical Center, Dallas, TX.
• ⁵ Department Oncology, University College London Cancer Institute, London, UK.
• ⁶ Department of Internal Medicine, Mainz University Medical Center, Mainz, Germany.
• ⁷ Department of Radiology, University of Pisa School of Medicine, Pisa, Italy.
• ⁸ Miami Cancer Institute, Miami, FL.
• ⁹ Gastrointestinal Malignancy Section, Thoracic and Gastrointestinal Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD.
• ¹⁰ Department of Gastroenterology and Hepatology, Kindai University Faculty of Medicine, Osaka, Japan.
• ¹¹ Department of Health Sciences Research, Mayo Clinic, Rochester, MN.
• ¹² Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA.
• ¹³ Jiahui International Cancer Center, Shanghai, China.
• ¹⁴ Geffen School of Medicine at UCLA, Los Angeles, CA.
• ¹⁵ Gastroenterology & Hepatology Department, Mayo Clinic, Rochester, MN.